The bulk of Mylan’s product portfolio, which consists of more than 1000 individual products, includes high quality, more affordable generic medications sold throughout the world. Generic drugs are tried-and-true versions of brand-name pharmaceuticals and have been used by millions for decades. While the active pharmaceutical ingredient in a generic drug and its proprietary counterpart are chemically identical, generic drugs typically cost far less than brand-name drugs because their producers don’t have to invent them from scratch. To learn more about generic drugs visit www.ChoosingGenerics.com
The generics industry continues to grow as an aging population, a strong desire to reduce health care outlays, and an increasing reliance on generics continue to fuel demand. Mylan is armed and ready to continue to seamlessly and efficiently deliver high quality products at competitive prices that offer solutions to health care demands across the globe.
Mylan innovates every day to be among the first to bring new generics to market. Introducing groundbreaking delivery technologies, and difficult-to-manufacture and difficult-to-formulate pharmaceuticals are just a few of the ways Mylan demonstrates that it is anything but generic.